Beta-adrenergic blocking drugs in breast cancer: a perspective review

Beta-Blocker Drug Therapy Reduces Secondary Cancer Formation in Breast Cancer and Improves Cancer Specific Survival

(2015)   Oncotarget

Can all beta blockers improve the breast cancer survival?

(2011) Mehmet Ali Nahit Sendur et al.   BREAST

Alpha- and beta-adrenergic receptor (AR) protein expression is associated with poor clinical outcome in breast cancer: an immunohistochemical study

(2011) D. G. Powe et al.   BREAST CANCER RESEARCH AND TREATMENT

Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort

(2011) Patricia A. Ganz et al.   BREAST CANCER RESEARCH AND TREATMENT

β-Adrenergic receptors (β-AR) regulate VEGF and IL-6 production by divergent pathways in high β-AR-expressing breast cancer cell lines

(2011) Kelley S. Madden et al.   BREAST CANCER RESEARCH AND TREATMENT

Does β-adrenoceptor blocker therapy improve cancer survival? Findings from a population-based retrospective cohort study

(2011) Sunil M. Shah et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

β2-adrenoceptor blocker synergizes with gemcitabine to inhibit the proliferation of pancreatic cancer cells via apoptosis induction

(2011) Tao Shan et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Expanding Our Therapeutic Options: Beta Blockers for Breast Cancer?

(2011) Patricia A. Ganz et al.   JOURNAL OF CLINICAL ONCOLOGY

Beta Blockers and Breast Cancer Mortality: A Population- Based Study

(2011) Thomas I. Barron et al.   JOURNAL OF CLINICAL ONCOLOGY

Beta-Blocker Use Is Associated With Improved Relapse-Free Survival in Patients With Triple-Negative Breast Cancer

(2011) Amal Melhem-Bertrandt et al.   JOURNAL OF CLINICAL ONCOLOGY

Synergism between immunostimulation and prevention of surgery-induced immune suppression: An approach to reduce post-operative tumor progression

(2010) Roi Avraham et al.   BRAIN BEHAVIOR AND IMMUNITY

The β2-adrenergic receptor and Her2 comprise a positive feedback loop in human breast cancer cells

(2010) Ming Shi et al.   BREAST CANCER RESEARCH AND TREATMENT

Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action

(2010) C.H. Storch et al.   BRITISH JOURNAL OF DERMATOLOGY

β2-adrenergic antagonists suppress pancreatic cancer cell invasion by inhibiting CREB, NF-κB and AP-1

(2010) Dong Zhang et al.   CANCER BIOLOGY & THERAPY

The Sympathetic Nervous System Induces a Metastatic Switch in Primary Breast Cancer

(2010) E. K. Sloan et al.   CANCER RESEARCH

445 Beta-blocker treatment is associated with a reduction in tumour metastasis and an improvement in specific survival in patients with breast cancer

(2010) D.G. Powe et al.   EJC SUPPLEMENTS

Efficacy and safety of propranolol as first-line treatment for infantile hemangiomas

(2010) Clemens Schiestl et al.   EUROPEAN JOURNAL OF PEDIATRICS

Norepinephrine induces VEGF expression and angiogenesis by a hypoxia-inducible factor-1α protein-dependent mechanism

(2010) Soon Young Park et al.   INTERNATIONAL JOURNAL OF CANCER

Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis

(2010) Anil K. Sood et al.   JOURNAL OF CLINICAL INVESTIGATION

Host Factors and Cancer Outcome

(2010) Pamela J. Goodwin et al.   JOURNAL OF CLINICAL ONCOLOGY

Host Factors and Cancer Progression: Biobehavioral Signaling Pathways and Interventions

(2010) Susan K. Lutgendorf et al.   JOURNAL OF CLINICAL ONCOLOGY

Improving Survival Rates in Two Models of Spontaneous Postoperative Metastasis in Mice by Combined Administration of a β-Adrenergic Antagonist and a Cyclooxygenase-2 Inhibitor

(2010) Ariella Glasner et al.   JOURNAL OF IMMUNOLOGY

β-Adrenergic Receptors in Cancer: Therapeutic Implications

(2010) Mario Pérez-Sayáns et al.   ONCOLOGY RESEARCH

Silencing or Fueling Metastasis with VEGF Inhibitors: Antiangiogenesis Revisited

(2009) Sonja Loges et al.   CANCER CELL

Surgical Stress Promotes Tumor Growth in Ovarian Carcinoma

(2009) J.-W. Lee et al.   CLINICAL CANCER RESEARCH

Perioperative Use of β-blockers and COX-2 Inhibitors May Improve Immune Competence and Reduce the Risk of Tumor Metastasis

(2008) Marganit Benish et al.   ANNALS OF SURGICAL ONCOLOGY

Neuroendocrine modulation of cancer progression

(2008) Guillermo N. Armaiz-Pena et al.   BRAIN BEHAVIOR AND IMMUNITY

Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: Implications for stress-related enhancement of tumor progression

(2008) Eric V. Yang et al.   BRAIN BEHAVIOR AND IMMUNITY

Epinephrine stimulates esophageal squamous-cell carcinoma cell proliferation via β-adrenoceptor-dependent transactivation of extracellular signal-regulated kinase/cyclooxygenase-2 pathway

(2008) Xuan Liu et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Inhibition of Pancreatic Cancer Cell Proliferation by Propranolol Occurs Through Apoptosis Induction

(2008) Dong Zhang et al.   PANCREAS

Do stress-related psychosocial factors contribute to cancer incidence and survival?

(2008) Yoichi Chida et al.   Nature clinical practice. Oncology

VEGF is differentially regulated in multiple myeloma-derived cell lines by norepinephrine

(2007) Eric V. Yang et al.   BRAIN BEHAVIOR AND IMMUNITY